Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-31 @ 4:16 PM
Study NCT ID:
NCT01311661
Status:
COMPLETED
Last Update Posted:
2014-05-01
First Post:
2011-03-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-03-04
First Submit QC Date:
None
Study First Post Date:
2011-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-28
Results First Submit QC Date:
None
Results First Post Date:
2014-05-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-28
Last Update Post Date:
2014-05-01
Last Update Post Date Type:
ESTIMATED